ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2774

Why Leg Ulcers Do Not Heal? a Prospective Study Showing High Proportion of Small Vessel Vasculitis

Vinod Ravindran1, Sunil Rajendran2 and Ranjish Vijayan2, 1National Hospital, Kozhikode, Kerala, India, 2PVS Hospital, Kozhikode, India

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: diagnosis, ulcers and vasculogenesis

  • Tweet
  • Email
  • Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Non healing cutaneous ulcers of lower limbs can have several different aetiologies [1]. It is likely that the patients with such ulcers would be treated with empirical therapies and may also undergo (unnecessary) venous procedures. Small vessel vasculitides (leucocytoclastic or non leucocytoclastic) are one of the important causes of non healing cutaneous leg ulcers [2]. The primary objective of this prospective study was to ascertain the cause of non healing cuatneous ulcers of the lower limbs.
Methods: Between May 2010 and April 2013 (3years) consecutive adult patients (age 18 to 75 years) who had one or more persistent leg ulcers (with or without a history of recurrent ulcerations in legs) for more than 2 years presenting to us were prospectively enrolled. Relevant details were extracted using a predefined proforma and included: demographic details, drug history, comorbidities, clinical features, investigations including ANCA, complement levels, cryoglobuilins, HIV and Hepatitis viral serology etc. and venous and arterial Dopplers, microscopy and culture of the ulcer swab in instances of infected looking ulcers. Previous biopsies were reveiwd and fresh biopsies were obtained from the ulcer edges and also from the nonulcerated sites where suitable skin lesions were also present. In cases of ulcers deemed to be a manifestation of a primary systemic vasculitis based on the EMEA classification, BVAS was used to assess disease activity.
Results: A total of 51 patients were assessed. Mean age was 53 ± 10.3 years and 39 (76%) were male. Eight (16%) patients were diabetic. History of some type of venous surgery was present in 30 (59%) and 9 had such procedures more than once. Biopsy
confirmed small vessel vasculitis of various types in a majority (76%) of patients (table 1). Drug induced cutaneous vasculitis was not present in this cohort.

Table 1
Aeitiology n(%) Comments
Small vessel Vasculitis 39(76%) All biopsy proven
Chronic infections 4 (8%) Mainly Stap. epidermidis
No apparent single cause 8 (16%) Likely mixed aetiology

In 9 (18%) patients the leg ulcers were one of the manifestations of a primary systemic vasculitis i.e GPA (4), EGPA(2), MPA(2) and PAN (1). Leg ulcers in these patients ran an indolent course with a variety of low to moderate grade of activity features reflected also in the BVAS range of 9 to 15. All patients with small vessel vasculitis were treated with immunosuppressive therapy including glucocorticoids with good effect [complete healing of ulcer(s) in 21 patients with no relapse in 24 weeks of follow up period].
Conclusion: In this cohort of patients with chronic non healing leg ulcers small vessel cutaneous vasculitis emerged as the leading cause and majority benifitted from subsequently instituted specific measures of treatment.
References: 1. Mekess JR et al. Causes, investigation and treatment of leg ulceration. British Journal of Dermatology 2003; 148: 388–401.
2. Gonzalez-Gay MA et. Other vasculitides including small-vessel vasculitis. In: Oxford Textbook of Rheumatology 3rd ed, Isenberg DA et al (eds). OUP 2004, pp983-988.


Disclosure:

V. Ravindran,
None;

S. Rajendran,
None;

R. Vijayan,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/why-leg-ulcers-do-not-heal-a-prospective-study-showing-high-proportion-of-small-vessel-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology